Suchergebnisse - "Kow, Chia Siang"

PubPharm (36)

11

Preadmission use of inhaled corticosteroids and risk of fatal or severe COVID-19 : a meta-analysis

enthalten in: The Journal of asthma : official journal of the Association for the Care of Asthma | 2022

von Kow, C. | Hasan, S.

CommentOn: J Asthma. 2021 Nov;58(11):1536-1543. - PMID 32779943

12

Clinical outcomes of sofosbuvir-based antivirals in patients with COVID-19 : a systematic review and meta-analysis of randomized trials

enthalten in: Expert review of anti-infective therapy | 2022

von Kow, C. | Javed, A. | Ramachandram, D. | +1

13

The Association Between the Use of Statins and Clinical Outcomes in Patients with COVID-19 : A Systematic Review and Meta-analysis

enthalten in: American journal of cardiovascular drugs : drugs, devices, and other interventions | 2022

von Kow, C. | Hasan, S.

14

Clinical outcomes of hypertensive patients with COVID-19 receiving calcium channel blockers : a systematic review and meta-analysis

enthalten in: Hypertension research : official journal of the Japanese Society of Hypertension | 2022

von Kow, C. | Ramachandram, D. | Hasan, S.

15

The use of neutralizing monoclonal antibodies and risk of hospital admission and mortality in patients with COVID-19 : a systematic review and meta-analysis of randomized trials

enthalten in: Immunopharmacology and immunotoxicology | 2022

von Kow, C. | Ramachandram, D. | Hasan, S.

16

The effect of higher-intensity dosing of anticoagulation on the clinical outcomes in hospitalized patients with COVID-19 : A meta-analysis of randomized controlled trials

enthalten in: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy | 2022

von Kow, C. | Ramachandram, D. | Hasan, S.

17

The effect of colchicine on mortality outcome and duration of hospital stay in patients with COVID-19 : A meta-analysis of randomized trials

enthalten in: Immunity, inflammation and disease | 2022

von Kow, C. | Lee, L. | Ramachandram, D. | +3

18

Use of Calcium Channel Blockers and the Risk of All-cause Mortality and Severe Illness in Patients With COVID-19 : A Systematic Review and Meta-analysis

enthalten in: Journal of cardiovascular pharmacology | 2022

von Kow, C. | Ramachandram, D. | Hasan, S.

19

IL-6 antagonists to replace systemic corticosteroids as the preferred anti-inflammatory therapy in patients with COVID-19?

enthalten in: Cytokine | 2022

von Kow, C. | Zaihan, A. | Ramachandram, D. | +1

20

Future of antivirals in COVID-19 : The case of favipiravir

enthalten in: International immunopharmacology | 2022

von Kow, C. | Ramachandram, D. | Hasan, S.